Concepedia
Statistics
Publications
6
Citations
392
H-Index
Active since
2002
Affiliations
Sarepta Therapeutics (United States)(Current)
Oregon Health & Science University
Oregon State University
Corvallis Environmental Center
Carla A. London is an author at Sarepta Therapeutics (United States) specializing in medicine, molecular oncology, and oncology.
Publications per year
2002–2007
X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells
Adams Amantana, Carla A. London, Patrick L. Iversen et al. · Molecular Cancer Therapeutics · 2004 · 152 citations · Full text
Medicine, Oncology, Pharmacology +17
A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity
Carla A. London, Harmanjatinder S. Sekhon, Vikram Arora et al. · Cancer Gene Therapy · 2003 · 94 citations
Medicine, Oncology, Pharmacology +15
c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model
Harmanjatinder S. Sekhon, Carla A. London, Mypinder S. Sekhon et al. · Lung Cancer · 2007 · 45 citations
Medicine, Cancer Biology, Oncology +12
Inhibition of human chorionic gonadotropin β‐subunit modulates the mitogenic effect of <i>c‐myc</i> in human prostate cancer cells
Gayathri R. Devi, Jennifer R. Oldenkamp, Carla A. London et al. · The Prostate · 2002 · 38 citations
Medicine, Molecular Biology, Oncology +17
Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing
Nikki B. Marshall, Shannon K. Oda, Carla A. London et al. · Journal of Immunological Methods · 2007 · 34 citations
Pharmacy, Immunology, Molecular Biology +17
1–5 of 6